Crossvault Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$9.29M Sell
52,342
-440
-0.8% -$78.4K 3.66% 8
2022
Q1
$9.35M Sell
52,782
-420
-0.8% -$71.5K 3.01% 13
2021
Q4
$9.1M Sell
53,202
-360
-0.7% -$58.9K 2.73% 13
2021
Q3
$8.65M Sell
53,562
-700
-1% -$119K 2.72% 16
2021
Q2
$9.34M Buy
54,262
+886
+2% +$147K 2.85% 13
2021
Q1
$8.77M Buy
53,376
+555
+1% +$89.8K 3.13% 11
2020
Q4
$8.31M Buy
52,821
+1,066
+2% +$157K 3.09% 13
2020
Q3
$7.71M Buy
51,755
+1,248
+2% +$185K 3.35% 13
2020
Q2
$7.1M Sell
50,507
-272
-0.5% -$39.6K 3.29% 9
2020
Q1
$6.66M Buy
50,779
+199
+0.4% +$28.2K 3.73% 7
2019
Q4
$7.38M Buy
50,580
+90
+0.2% +$12.2K 3.23% 12
2019
Q3
$6.53M Sell
50,490
-175
-0.3% -$23.1K 3.12% 12
2019
Q2
$7.06M Buy
50,665
+480
+1% +$66.4K 3.46% 10
2019
Q1
$7.01M Hold
50,185
3.62% 9
2018
Q4
$6.48M Sell
50,185
-2,158
-4% -$301K 3.68% 9
2018
Q3
$7.23M Sell
52,343
-600
-1% -$79.7K 3.73% 10
2018
Q2
$6.42M Buy
52,943
+4,340
+9% +$541K 3.42% 14
2018
Q1
$6.23M Sell
48,603
-100
-0.2% -$13.5K 3.54% 12
2017
Q4
$6.8M Buy
48,703
+85
+0.2% +$11.8K 3.59% 9
2017
Q3
$6.32M Buy
48,618
+7,472
+18% +$990K 3.63% 9
2017
Q2
$5.44M Buy
41,146
+475
+1% +$60.6K 3.27% 12
2017
Q1
$5.07M Sell
40,671
-600
-1% -$71.7K 3.15% 12
2016
Q4
$4.75M Sell
41,271
-782
-2% -$90.3K 3.21% 12
2016
Q3
$4.97M Sell
42,053
-280
-0.7% -$34K 3.46% 8
2016
Q2
$5.13M Buy
42,333
+2,055
+5% +$234K 3.63% 8
2016
Q1
$4.36M Buy
40,278
+150
+0.4% +$15.5K 3.21% 12
2015
Q4
$4.12M Sell
40,128
-200
-0.5% -$20.1K 2.93% 15
2015
Q3
$3.77M Buy
40,328
+1,276
+3% +$123K 2.94% 16
2015
Q2
$3.81M Buy
39,052
+357
+0.9% +$35.8K 3.05% 14
2015
Q1
$3.89M Buy
38,695
+1,318
+4% +$134K 3.11% 10
2014
Q4
$3.91M Buy
37,377
+125
+0.3% +$13.2K 3.42% 9
2014
Q3
$3.97M Buy
37,252
+201
+0.5% +$20.8K 3.75% 6
2014
Q2
$3.88M Sell
37,051
-300
-0.8% -$30.3K 3.61% 7
2014
Q1
$3.67M Buy
37,351
+1,200
+3% +$111K 3.56% 8
2013
Q4
$3.31M Buy
+36,151
New +$3.33M 3.2% 11

Other funds holding JNJ

Crossvault Capital Management's JNJ Position: Q2 2022 in Review

Crossvault Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.83% in Q2 2022, selling an estimated $78.4K and leaving 52,342 shares worth $9.29M. The position accounts for 3.66% of the portfolio, ranked #8.

Crossvault Capital Management first reported a position in JNJ in Q4 2013 and has held it in 35 quarters since. The position peaked at $9.35M in Q1 2022. 3,671 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.

  • Crossvault Capital Management held 52,342 shares of Johnson & Johnson worth $9.29M as of Q2 2022.
  • Crossvault Capital Management sold 440 Johnson & Johnson shares in Q2 2022, an estimated $78.4K.
  • Johnson & Johnson made up 3.66% of Crossvault Capital Management's portfolio in Q2 2022, its #8 holding.
  • Crossvault Capital Management first reported a position in Johnson & Johnson in Q4 2013 and has held it in 35 quarters since.
  • Crossvault Capital Management's Johnson & Johnson position peaked at $9.35M in Q1 2022.
  • 3,671 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.

Based on Crossvault Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.